Literature DB >> 23109730

Antibody affinity maturation using yeast display with detergent-solubilized membrane proteins as antigen sources.

Benjamin J Tillotson1, Iñigo F de Larrinoa, Colin A Skinner, Derek M Klavas, Eric V Shusta.   

Abstract

Antigen preparations in the form of detergent-solubilized cell lysates could, in principle, render membrane proteins (MPs) compatible with in vitro antibody engineering technologies. To this end, detergent-solubilized cell lysates were coupled with the yeast surface display platform to affinity mature an anti-transferrin receptor (TfR) single-chain antibody (scFv). Lysates were generated from TfR-expressing HEK293 cells by solubilization with detergent-containing buffer after undergoing plasma membrane-restricted biotinylation. Lysate-resident TfR was then combined with a mutagenic anti-TfR scFv library in a competitive, dissociation rate screen, and scFvs were identified with up to 4-fold improved dissociation rates on the surface of yeast. Importantly, although the lysates contained a complex mixture of biotinylated proteins, the engineered scFvs retained their TfR binding specificity. When secreted by yeast as soluble proteins, mutant scFvs bound to cell surface TfR with 3-7-fold improvements in equilibrium binding affinity. Although a known MP antigen was targeted for purposes of this study, employing biotin tagging as a means of antigen detection makes the lysate-based approach particularly flexible. We have previously shown that yeast display can be used to identify lead antibodies using cell lysate-resident MP antigens, and combined with this work showing that antibodies can also be quantitatively engineered using cell lysates, these approaches may provide a high-throughput platform for generation and optimization of antibodies against MPs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23109730      PMCID: PMC3542525          DOI: 10.1093/protein/gzs077

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  55 in total

1.  Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 degrees C.

Authors:  Christilyn P Graff; Kerry Chester; Richard Begent; K Dane Wittrup
Journal:  Protein Eng Des Sel       Date:  2004-04-28       Impact factor: 1.650

2.  Plasmid construction by homologous recombination in yeast.

Authors:  H Ma; S Kunes; P J Schatz; D Botstein
Journal:  Gene       Date:  1987       Impact factor: 3.688

3.  Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity.

Authors:  Ka Yin Kwong; Sivasubramanian Baskar; Hua Zhang; Crystal L Mackall; Christoph Rader
Journal:  J Mol Biol       Date:  2008-09-16       Impact factor: 5.469

4.  Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection.

Authors:  R Schier; J Bye; G Apell; A McCall; G P Adams; M Malmqvist; L M Weiner; J D Marks
Journal:  J Mol Biol       Date:  1996-01-12       Impact factor: 5.469

5.  Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation.

Authors:  B F Haynes; M Hemler; T Cotner; D L Mann; G S Eisenbarth; J L Strominger; A S Fauci
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

6.  Domain association in immunoglobulin molecules. The packing of variable domains.

Authors:  C Chothia; J Novotný; R Bruccoleri; M Karplus
Journal:  J Mol Biol       Date:  1985-12-05       Impact factor: 5.469

7.  Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities.

Authors:  Adam P Silverman; Aron M Levin; Jennifer L Lahti; Jennifer R Cochran
Journal:  J Mol Biol       Date:  2008-11-12       Impact factor: 5.469

8.  An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues.

Authors:  M Zaccolo; D M Williams; D M Brown; E Gherardi
Journal:  J Mol Biol       Date:  1996-02-02       Impact factor: 5.469

9.  Heterogeneity of the human transferrin receptor and use of anti-transferrin receptor antibodies to detect tumours in vivo.

Authors:  M Panaccio; J R Zalcberg; C H Thompson; M J Leyden; J R Sullivan; M Lichtenstein; I F McKenzie
Journal:  Immunol Cell Biol       Date:  1987-12       Impact factor: 5.126

10.  The critical glycosylation site of human transferrin receptor contains a high-mannose oligosaccharide.

Authors:  G R Hayes; A Williams; C E Costello; C A Enns; J J Lucas
Journal:  Glycobiology       Date:  1995-03       Impact factor: 4.313

View more
  8 in total

1.  Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs.

Authors:  Kathryn E Tiller; Lijuan Li; Sandeep Kumar; Mark C Julian; Shekhar Garde; Peter M Tessier
Journal:  J Biol Chem       Date:  2017-08-04       Impact factor: 5.157

2.  A yeast display immunoprecipitation screen for targeted discovery of antibodies against membrane protein complexes.

Authors:  Jason M Lajoie; Yong Ku Cho; Dustin Frost; Samantha Bremner; Lingjun Li; Eric V Shusta
Journal:  Protein Eng Des Sel       Date:  2019-12-31       Impact factor: 1.650

3.  Yeast Display-Based Antibody Affinity Maturation Using Detergent-Solubilized Cell Lysates.

Authors:  Benjamin J Tillotson; Jason M Lajoie; Eric V Shusta
Journal:  Methods Mol Biol       Date:  2015

4.  Titratable Avidity Reduction Enhances Affinity Discrimination in Mammalian Cellular Selections of Yeast-Displayed Ligands.

Authors:  Lawrence A Stern; Clifford M Csizmar; Daniel R Woldring; Carston R Wagner; Benjamin J Hackel
Journal:  ACS Comb Sci       Date:  2017-03-31       Impact factor: 3.784

5.  Engineering an Anti-Transferrin Receptor ScFv for pH-Sensitive Binding Leads to Increased Intracellular Accumulation.

Authors:  Benjamin J Tillotson; Loukas I Goulatis; Isabelle Parenti; Elizabeth Duxbury; Eric V Shusta
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

6.  Identification of lamprey variable lymphocyte receptors that target the brain vasculature.

Authors:  Jason M Lajoie; Moriah E Katt; Elizabeth A Waters; Brantley R Herrin; Eric V Shusta
Journal:  Sci Rep       Date:  2022-04-11       Impact factor: 4.379

7.  Addressing Barriers to the Development and Adoption of Rapid Diagnostic Tests in Global Health.

Authors:  Eric Miller; Hadley D Sikes
Journal:  Nanobiomedicine (Rij)       Date:  2015-06-29

8.  Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.

Authors:  Julie A Douthwaite; Sudharsan Sridharan; Catherine Huntington; Jayne Hammersley; Rose Marwood; Jonna K Hakulinen; Margareta Ek; Tove Sjögren; David Rider; Cyril Privezentzev; Jonathan C Seaman; Peter Cariuk; Vikki Knights; Joyce Young; Trevor Wilkinson; Matthew Sleeman; Donna K Finch; David C Lowe; Tristan J Vaughan
Journal:  MAbs       Date:  2015       Impact factor: 5.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.